Effect of highly purified eicosapentaenoic acid on psoriasis.
Kojima
T
T
Department of Dermatology, Chiba University School of Medicine.
Terano
T
T
Tanabe
E
E
Okamoto
S
S
Tamura
Y
Y
Yoshida
S
S
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000031:analogs & derivatives; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000378:metabolism; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy*
D007975:Leukotriene B4; C040212:leukotriene B5; D015118:Eicosapentaenoic Acid